-transparent.png){kind=logo}
Tamsulosin, sold under the brand name Flomax, is a commonly prescribed medication for benign prostatic hypertrophy (BPH). While generally well-tolerated, this medication can induce life-threatening tachyarrhythmias. Early recognition of this adverse effect can lead to prompt discontinuation of the therapy in an effort to reduce arrhythmia recurrence. Herein we describe a case of atrial fibrillation with rapid ventricular response in a male patient who started on tamsulosin two days prior.
| UI | MeSH Term | Description | Entries |
|---|
Related Publications
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
September 2008,
Taiwanese journal of obstetrics & gynecology,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
May 2018,
Cureus,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
December 2023,
The American journal of emergency medicine,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
June 2019,
British journal of hospital medicine (London, England : 2005),
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
October 2011,
The American journal of emergency medicine,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
June 2022,
JACC. Clinical electrophysiology,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
November 2013,
The Journal of emergency medicine,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
March 2023,
Annals of emergency medicine,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
November 2020,
Cureus,
Duncan McGuire, and
Heaveen Ahdi, and
Nicholas Mielke, and
Amit Bahl
October 2000,
Europace : European pacing, arrhythmias, and cardiac electrophysiology : journal of the working groups on cardiac pacing, arrhythmias, and cardiac cellular electrophysiology of the European Society of Cardiology,
